• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Segmentum:一种用于癌症基因组拷贝数分析的工具。

Segmentum: a tool for copy number analysis of cancer genomes.

作者信息

Afyounian Ebrahim, Annala Matti, Nykter Matti

机构信息

Faculty of Medicine and Life Sciences and BioMediTech institute, University of Tampere, Tampere, Finland.

出版信息

BMC Bioinformatics. 2017 Apr 13;18(1):215. doi: 10.1186/s12859-017-1626-8.

DOI:10.1186/s12859-017-1626-8
PMID:28407731
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5390478/
Abstract

BACKGROUND

Somatic alterations, including loss of heterozygosity, can affect the expression of oncogenes and tumor suppressor genes. Whole genome sequencing enables detailed characterization of such aberrations. However, due to the limitations of current high throughput sequencing technologies, this task remains challenging. Hence, accurate and reliable detection of such events is crucial for the identification of cancer-related alterations.

RESULTS

We introduce a new tool called Segmentum for determining somatic copy numbers using whole genome sequencing from paired tumor/normal samples. In our approach, read depth and B-allele fraction signals are smoothed, and double sliding windows are used to detect breakpoints, which makes our approach fast and straightforward. Because the breakpoint detection is performed simultaneously at different scales, it allows accurate detection as suggested by the evaluation results from simulated and real data. We applied Segmentum to paired tumor/normal whole genome sequencing samples from 38 patients with low-grade glioma from the TCGA dataset and were able to confirm the recurrence of copy-neutral loss of heterozygosity in chromosome 17p in low-grade astrocytoma characterized by IDH1/2 mutation and lack of 1p/19q co-deletion, which was previously reported using SNP array data.

CONCLUSIONS

Segmentum is an accurate, user-friendly tool for somatic copy number analysis of tumor samples. We demonstrate that this tool is suitable for the analysis of large cohorts, such as the TCGA dataset.

摘要

背景

体细胞改变,包括杂合性缺失,可影响癌基因和肿瘤抑制基因的表达。全基因组测序能够详细表征此类畸变。然而,由于当前高通量测序技术的局限性,这项任务仍然具有挑战性。因此,准确可靠地检测此类事件对于识别癌症相关改变至关重要。

结果

我们引入了一种名为Segmentum的新工具,用于使用配对肿瘤/正常样本的全基因组测序来确定体细胞拷贝数。在我们的方法中,读取深度和B等位基因分数信号被平滑处理,并使用双滑动窗口来检测断点,这使得我们的方法快速且直接。由于断点检测是在不同尺度上同时进行的,根据模拟和真实数据的评估结果,它能够进行准确检测。我们将Segmentum应用于来自TCGA数据集的38例低级别胶质瘤患者的配对肿瘤/正常全基因组测序样本,并能够证实先前使用SNP阵列数据报道的、以IDH1/2突变和缺乏1p/19q共缺失为特征的低级别星形细胞瘤中17号染色体短臂上拷贝数中性杂合性缺失的复发情况。

结论

Segmentum是一种用于肿瘤样本体细胞拷贝数分析的准确、用户友好的工具。我们证明该工具适用于分析大型队列,如TCGA数据集。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e223/5390478/7ad91a2906ed/12859_2017_1626_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e223/5390478/090eb6a3c47d/12859_2017_1626_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e223/5390478/c166dd5f48c5/12859_2017_1626_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e223/5390478/7be5f2db6d73/12859_2017_1626_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e223/5390478/963566ebf7e4/12859_2017_1626_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e223/5390478/8f927762fcfc/12859_2017_1626_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e223/5390478/7ad91a2906ed/12859_2017_1626_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e223/5390478/090eb6a3c47d/12859_2017_1626_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e223/5390478/c166dd5f48c5/12859_2017_1626_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e223/5390478/7be5f2db6d73/12859_2017_1626_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e223/5390478/963566ebf7e4/12859_2017_1626_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e223/5390478/8f927762fcfc/12859_2017_1626_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e223/5390478/7ad91a2906ed/12859_2017_1626_Fig6_HTML.jpg

相似文献

1
Segmentum: a tool for copy number analysis of cancer genomes.Segmentum:一种用于癌症基因组拷贝数分析的工具。
BMC Bioinformatics. 2017 Apr 13;18(1):215. doi: 10.1186/s12859-017-1626-8.
2
Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma.应用靶向二代测序评估 IDH 突变型 II 级胶质瘤的突变和拷贝数改变的预后相关性。
J Neurooncol. 2018 Sep;139(2):349-357. doi: 10.1007/s11060-018-2867-8. Epub 2018 Apr 16.
3
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.胶质瘤中1p36和19q13的等位基因缺失:与组织学分类的相关性、1p36上150kb最小缺失区域的定义以及CAMTA1作为候选肿瘤抑制基因的评估
Clin Cancer Res. 2005 Feb 1;11(3):1119-28.
4
Next-Generation Sequencing Panel for 1p/19q Codeletion and IDH1-IDH2 Mutational Analysis Uncovers Mistaken Overdiagnoses of 1p/19q Codeletion by FISH.下一代测序 panel 用于 1p/19q 共缺失和 IDH1-IDH2 突变分析,揭示了 FISH 对 1p/19q 共缺失的误诊。
J Mol Diagn. 2021 Sep;23(9):1185-1194. doi: 10.1016/j.jmoldx.2021.06.004. Epub 2021 Jun 26.
5
Genome-Wide Copy Number Variation Detection Using NGS: Data Analysis and Interpretation.使用二代测序技术进行全基因组拷贝数变异检测:数据分析与解读
Methods Mol Biol. 2019;1908:113-124. doi: 10.1007/978-1-4939-9004-7_8.
6
Targeted next-generation sequencing panel (TruSight Tumor 170) in diffuse glioma: a single institutional experience of 135 cases.针对弥漫性神经胶质瘤的靶向下一代测序面板(TruSight Tumor 170):单机构 135 例经验。
J Neurooncol. 2019 May;142(3):445-454. doi: 10.1007/s11060-019-03114-1. Epub 2019 Feb 1.
7
Shallow whole-genome sequencing: a useful, easy to apply molecular technique for CNA detection on FFPE tumor tissue-a glioma-driven study.浅全基因组测序:一种在 FFPE 肿瘤组织中检测 CNA 的有用且易于应用的分子技术——一项胶质瘤驱动的研究。
Virchows Arch. 2022 Mar;480(3):677-686. doi: 10.1007/s00428-022-03268-w. Epub 2022 Jan 16.
8
Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.17号染色体短臂拷贝数中性杂合性缺失及TP53基因纯合突变与新诊断的骨髓增生异常综合征患者的复杂染色体畸变相关。
Leuk Res. 2016 Mar;42:7-12. doi: 10.1016/j.leukres.2016.01.009. Epub 2016 Jan 24.
9
Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data.Sequenza:来自肿瘤测序数据的等位基因特异性拷贝数和突变图谱。
Ann Oncol. 2015 Jan;26(1):64-70. doi: 10.1093/annonc/mdu479. Epub 2014 Oct 15.
10
Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中复发性拷贝数改变和拷贝数中性杂合性缺失的全基因组分析。
J Oral Pathol Med. 2014 Jan;43(1):20-7. doi: 10.1111/jop.12087. Epub 2013 Jun 10.

引用本文的文献

1
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
2
SEG - A Software Program for Finding Somatic Copy Number Alterations in Whole Genome Sequencing Data of Cancer.SEG - 一种用于在癌症全基因组测序数据中查找体细胞拷贝数改变的软件程序。
Comput Struct Biotechnol J. 2018 Sep 7;16:335-341. doi: 10.1016/j.csbj.2018.09.001. eCollection 2018.

本文引用的文献

1
A global reference for human genetic variation.人类遗传变异的全球参考。
Nature. 2015 Oct 1;526(7571):68-74. doi: 10.1038/nature15393.
2
Mutational landscape and clonal architecture in grade II and III gliomas.二级和三级神经胶质瘤中的突变特征和克隆结构。
Nat Genet. 2015 May;47(5):458-68. doi: 10.1038/ng.3273. Epub 2015 Apr 13.
3
CLImAT: accurate detection of copy number alteration and loss of heterozygosity in impure and aneuploid tumor samples using whole-genome sequencing data.CLImAT:利用全基因组测序数据准确检测不纯和非整倍体肿瘤样本中的拷贝数改变和杂合性缺失。
Bioinformatics. 2014 Sep 15;30(18):2576-83. doi: 10.1093/bioinformatics/btu346. Epub 2014 May 19.
4
Comparative analysis of methods for identifying somatic copy number alterations from deep sequencing data.从深度测序数据中识别体细胞拷贝数改变的方法的比较分析。
Brief Bioinform. 2015 Mar;16(2):242-54. doi: 10.1093/bib/bbu004. Epub 2014 Mar 5.
5
Computational tools for copy number variation (CNV) detection using next-generation sequencing data: features and perspectives.基于新一代测序数据的拷贝数变异(CNV)检测的计算工具:特点和展望。
BMC Bioinformatics. 2013;14 Suppl 11(Suppl 11):S1. doi: 10.1186/1471-2105-14-S11-S1. Epub 2013 Sep 13.
6
Computational methods for detecting copy number variations in cancer genome using next generation sequencing: principles and challenges.利用下一代测序技术检测癌症基因组中拷贝数变异的计算方法:原理与挑战
Oncotarget. 2013 Nov;4(11):1868-81. doi: 10.18632/oncotarget.1537.
7
THetA: inferring intra-tumor heterogeneity from high-throughput DNA sequencing data.THetA:从高通量 DNA 测序数据推断肿瘤内异质性。
Genome Biol. 2013 Jul 29;14(7):R80. doi: 10.1186/gb-2013-14-7-r80.
8
Patchwork: allele-specific copy number analysis of whole-genome sequenced tumor tissue.拼凑法:对全基因组测序肿瘤组织进行等位基因特异性拷贝数分析
Genome Biol. 2013 Mar 25;14(3):R24. doi: 10.1186/gb-2013-14-3-r24.
9
Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer.全基因组杂合性缺失和核苷酸分辨率下单等位基因表达的综合分析揭示了三阴性乳腺癌中失调的通路。
Genome Res. 2012 Oct;22(10):1995-2007. doi: 10.1101/gr.137570.112. Epub 2012 May 25.
10
Absolute quantification of somatic DNA alterations in human cancer.人类癌症中体细胞 DNA 改变的绝对定量。
Nat Biotechnol. 2012 May;30(5):413-21. doi: 10.1038/nbt.2203.